论文部分内容阅读
目的:探讨呼吸内科老年肺结核治疗中应用生脉注射液的疗效。方法:选取我院呼吸内科在2008年10年~2013年10月收治的126例老年肺结核患者作为研究对象,随机分为2组(每组63例):对照组实施常规抗结核治疗,观察组在对照组的治疗基础上,加用生脉注射液,对比两组患者的治疗效果和痰菌转阴情况。结果:观察组的显效率为79.4%(50/63),显著高于对照组的55.6%(35/63),P<0.05;治疗有效率为96.8%,显著高于对照组的84.1%,P<0.05,差异具有统计学意义;治疗前,两组患者的痰菌培养结果均呈阳性;治疗后,观察组的痰菌转阴率为93.7%,对照组为73.0%,组间比较,差异有统计学意义,P<0.05。结论:在老年肺结核的临床治疗中,应用生脉注射液可有效增强机体免疫力,快速缓解临床症状,加快病变吸收,提高治疗效果,值得推广应用。
Objective: To investigate the effect of Shengmai injection in the treatment of senile pulmonary tuberculosis in respiratory medicine. Methods: A total of 126 elderly patients with pulmonary tuberculosis who were admitted to our department of respiratory medicine from October 2008 to October 2013 were randomly divided into 2 groups (63 in each group): the control group received routine antituberculous therapy, and the observation group In the control group based on the treatment, plus Shengmai injection, the two groups were compared the therapeutic effect and sputum negative conversion. Results: The effective rate of observation group was 79.4% (50/63), significantly higher than 55.6% (35/63) in control group, P <0.05; the effective rate of treatment was 96.8%, significantly higher than that of control group (84.1% P <0.05, the difference was statistically significant; before treatment, the sputum culture results of both groups were positive; after treatment, the sputum negative rate of the observation group was 93.7%, the control group was 73.0% The difference was statistically significant, P <0.05. Conclusion: In the clinical treatment of senile pulmonary tuberculosis, the application of Shengmai injection can effectively enhance the body immunity, quickly relieve clinical symptoms, speed up the absorption of lesions and improve the therapeutic effect, which is worth popularizing and applying.